Crumplin G C
Biology Department, University of York, UK.
J Antimicrob Chemother. 1990 Dec;26 Suppl F:131-44. doi: 10.1093/jac/26.suppl_f.131.
Because of the close structural relationship of the fluorinated 4-quinolones to the parent compound nalidixic acid the mechanism of resistance is often perceived to be the same. However, it is clear that whilst the mechanism of resistance to fluorinated 4-quinolones is essentially the same, strains that are selected as resistant to nalidixic acid generally retain sensitivity to the newer agents. A number of mutations in the chromosome of Escherichia coli have been identified and these are described. These mutations affect the interaction of quinolones with their presumed targets (DNA gyrases) and the transport of quinolones through the cell membrane. A small number of other mutations giving rise to low-level resistance to nalidixic acid, which affect neither gyrase nor membrane function, are also recognized. Despite the recognition of these mutations, the practical application of this information is hampered by lack of knowledge of the normal uptake mechanisms, the processes involved in selection and maintenance of resistance, the relationship of resistance to pathogenicity and the frequency of occurrence of these mutations.
由于氟化4-喹诺酮与母体化合物萘啶酸在结构上密切相关,人们常常认为它们的耐药机制相同。然而,很明显,虽然对氟化4-喹诺酮的耐药机制基本相同,但对萘啶酸耐药的菌株通常对新型药物仍保持敏感。已在大肠杆菌染色体中鉴定出一些突变,并对这些突变进行了描述。这些突变影响喹诺酮与其假定靶点(DNA促旋酶)的相互作用以及喹诺酮通过细胞膜的转运。还发现了少数其他导致对萘啶酸低水平耐药的突变,这些突变既不影响促旋酶也不影响膜功能。尽管已经认识到这些突变,但由于对正常摄取机制、耐药性的选择和维持过程、耐药性与致病性的关系以及这些突变的发生频率缺乏了解,这些信息的实际应用受到了阻碍。